Literature DB >> 8732431

Fu-Ling, a Chinese herbal drug, modulates cytokine secretion by human peripheral blood monocytes.

S J Yu1, J Tseng.   

Abstract

Fu-Ling, the sclederma of Poria cocos (Schw.) Wolf, has long been used as a sedative and diuretic in traditional Chinese herbal medicine. Our study demonstrated that the substances extracted from Fu-Ling by 50% hot ethanol significantly augmented the secretion of interleukins IL-1 beta and IL-6 6 h after in vitro cultivation of human peripheral blood monocytes. The augmented effect was dose dependent. Tumour necrosis factor-alpha (TNF-alpha) secretion was also increased as the cells were treated with 0.4 mg/ml or higher doses of Fu-Ling extract. By contrast, Fu-Ling extract significantly suppressed the secretion of transforming growth factor-beta (TGF-beta) 3 h after the in vitro drug treatment. The suppressive effect was shown at doses as low as 0.2 mg/ml of Fu-Ling extract. Since Fu-Ling extract enhanced the secretion of immune stimulators (IL-1 beta, IL-6 and TNF-alpha) but suppressed the secretion of an immune suppressor (TGF-beta), the substance in 50% hot ethanol extract of Fu-Ling might have potentiated the immune response. Fu-Ling extract was further fractionated by reverse-phase column chromatography and high-performance liquid chromatography (HPLC). The components showing activity in modulating the cytokine secretion were relatively high in hydrophobicity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8732431     DOI: 10.1016/0192-0561(95)00103-4

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  8 in total

1.  Effect of Poria cocos hydroethanolic extract on treating adriamycin-induced rat model of nephrotic syndrome.

Authors:  Jun-Feng Zan; Chan-Juan Shen; Li-Ping Zhang; Yan-Wen Liu
Journal:  Chin J Integr Med       Date:  2016-12-29       Impact factor: 1.978

2.  The Effects of Poria cocos on Rho Signaling-Induced Regulation of Mobility and F-Actin Aggregation in MK-801-Treated B35 and C6 Cells.

Authors:  Yi-Chyan Chen; Chang-Ti Lee; Fu-Ming Tsai; Mao-Liang Chen
Journal:  Behav Neurol       Date:  2022-07-12       Impact factor: 3.112

3.  Poria cocos Modulates Th1/Th2 Response and Attenuates Airway Inflammation in an Ovalbumin-Sensitized Mouse Allergic Asthma Model.

Authors:  Chien-Liang Chao; Chao-Jih Wang; Hsin-Wen Huang; Han-Peng Kuo; Muh-Hwan Su; Hang-Ching Lin; Chia-Wen Teng; Leticia B Sy; Wen-Mein Wu
Journal:  Life (Basel)       Date:  2021-04-21

4.  In Vitro Effects of Dehydrotrametenolic Acid on Skin Barrier Function.

Authors:  Eunju Choi; Young-Gyu Kang; So-Hyeon Hwang; Jin Kyeong Kim; Yong Deog Hong; Won-Seok Park; Donghyun Kim; Eunji Kim; Jae Youl Cho
Journal:  Molecules       Date:  2019-12-14       Impact factor: 4.411

5.  Prescriptions of Chinese Herbal Medicines for Insomnia in Taiwan during 2002.

Authors:  Fang-Pey Chen; Maw-Shiou Jong; Yu-Chun Chen; Yen-Ying Kung; Tzeng-Ji Chen; Fun-Jou Chen; Shinn-Jang Hwang
Journal:  Evid Based Complement Alternat Med       Date:  2010-10-20       Impact factor: 2.629

6.  Clinical Efficacy of Traditional Chinese Medicine, Suan Zao Ren Tang, for Sleep Disturbance during Methadone Maintenance: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Yuan-Yu Chan; Yi-Hung Chen; Szu-Nian Yang; Wan-Yu Lo; Jaung-Geng Lin
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-04       Impact factor: 2.629

7.  Regulatory T Cell Induced by Poria cocos Bark Exert Therapeutic Effects in Murine Models of Atopic Dermatitis and Food Allergy.

Authors:  Min-Jung Bae; Hye-Jeong See; Gyeyoung Choi; Chang-Yuil Kang; Dong-Hwa Shon; Hee Soon Shin
Journal:  Mediators Inflamm       Date:  2016-06-29       Impact factor: 4.711

8.  Meta-Analysis on the Chinese Herbal Formula Xiaoer-Feike Granules as a Complementary Therapy for Children With Acute Lower Respiratory Infections.

Authors:  Qiang You; Lan Li; Dan Li; Dan Yang; Lin Chen; Hong-Ping Chen; You-Ping Liu
Journal:  Front Pharmacol       Date:  2020-10-22       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.